| Dr Richard Christian Malara, OD | |
|
8395 Oswego Rd, Kimbrook Village Square, Baldwinsville, NY 13027-6801 | |
| (315) 622-3500 | |
| (315) 622-3522 |
| Full Name | Dr Richard Christian Malara |
|---|---|
| Gender | Male |
| Speciality | Optometry |
| Experience | 32 Years |
| Location | 8395 Oswego Rd, Baldwinsville, New York |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1386634210 | NPI | - | NPPES |
| 1336346550 | Other | NY | CORPORATE NPI |
| 1386634210 | Other | NY | INDIVIDUAL NPI |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 152W00000X | Optometrist | TU005325-1 (New York) | Secondary |
| 152WC0802X | Optometrist - Corneal And Contact Management | TU005325-1 (New York) | Primary |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Richard C Malara Od Pc | 7719965839 | 4 |
News Archive
Vertex Pharmaceuticals Incorporated announced today that the U.S. Food and Drug Administration (FDA) has accepted the New Drug Application (NDA) for telaprevir and granted the company's request for six-month Priority Review. Telaprevir is Vertex's lead medicine in development for people with genotype 1 chronic hepatitis C.
Platelets, which allow blood to clot, are at the heart of numerous cardiovascular problems, including heart attacks and stroke. New research has uncovered a key platelet protein that could offer a new angle for developing drugs to prevent thrombosis, or dangerous blood clots, in patients who are at high risk such as those with atherosclerosis or a history of heart problems.
During the first day of the annual conference for the American Society for Radiation Oncology (ASTRO) in Miami, Nucletron, an Elekta company, today announced that it has received FDA 510(k) clearance for its new Vaginal CT/MR Multi Channel (VCMC) Applicator, offering a brachytherapy solution that enables very precise dose delivery for gynecologic cancers.
Research that provides a new understanding as to why ferrets are similar to humans is set to have major implications for the development of novel drugs and treatment strategies.
Researchers at Mayo Clinic's campus in Jacksonville say they have identified first steps in the origin of pancreatic cancer and that their findings suggest preventive strategies to explore.
› Verified 8 days ago
| Provider Name | Richard C Malara Od Pc |
|---|---|
| Provider Type | Part B Supplier - Clinic/group Practice |
| Provider Identifiers | NPI Number: 1336346550 PECOS PAC ID: 7719965839 Enrollment ID: O20040713001249 |
News Archive
Vertex Pharmaceuticals Incorporated announced today that the U.S. Food and Drug Administration (FDA) has accepted the New Drug Application (NDA) for telaprevir and granted the company's request for six-month Priority Review. Telaprevir is Vertex's lead medicine in development for people with genotype 1 chronic hepatitis C.
Platelets, which allow blood to clot, are at the heart of numerous cardiovascular problems, including heart attacks and stroke. New research has uncovered a key platelet protein that could offer a new angle for developing drugs to prevent thrombosis, or dangerous blood clots, in patients who are at high risk such as those with atherosclerosis or a history of heart problems.
During the first day of the annual conference for the American Society for Radiation Oncology (ASTRO) in Miami, Nucletron, an Elekta company, today announced that it has received FDA 510(k) clearance for its new Vaginal CT/MR Multi Channel (VCMC) Applicator, offering a brachytherapy solution that enables very precise dose delivery for gynecologic cancers.
Research that provides a new understanding as to why ferrets are similar to humans is set to have major implications for the development of novel drugs and treatment strategies.
Researchers at Mayo Clinic's campus in Jacksonville say they have identified first steps in the origin of pancreatic cancer and that their findings suggest preventive strategies to explore.
› Verified 8 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Richard Christian Malara, OD 8395 Oswego Rd, Baldwinsville, NY 13027-6801 Ph: (315) 622-3500 | Dr Richard Christian Malara, OD 8395 Oswego Rd, Kimbrook Village Square, Baldwinsville, NY 13027-6801 Ph: (315) 622-3500 |
News Archive
Vertex Pharmaceuticals Incorporated announced today that the U.S. Food and Drug Administration (FDA) has accepted the New Drug Application (NDA) for telaprevir and granted the company's request for six-month Priority Review. Telaprevir is Vertex's lead medicine in development for people with genotype 1 chronic hepatitis C.
Platelets, which allow blood to clot, are at the heart of numerous cardiovascular problems, including heart attacks and stroke. New research has uncovered a key platelet protein that could offer a new angle for developing drugs to prevent thrombosis, or dangerous blood clots, in patients who are at high risk such as those with atherosclerosis or a history of heart problems.
During the first day of the annual conference for the American Society for Radiation Oncology (ASTRO) in Miami, Nucletron, an Elekta company, today announced that it has received FDA 510(k) clearance for its new Vaginal CT/MR Multi Channel (VCMC) Applicator, offering a brachytherapy solution that enables very precise dose delivery for gynecologic cancers.
Research that provides a new understanding as to why ferrets are similar to humans is set to have major implications for the development of novel drugs and treatment strategies.
Researchers at Mayo Clinic's campus in Jacksonville say they have identified first steps in the origin of pancreatic cancer and that their findings suggest preventive strategies to explore.
› Verified 8 days ago
Optisight Ltd. Optometrist Medicare: Not Enrolled in Medicare Practice Location: 52 Oswego St, Baldwinsville, NY 13027 Phone: 315-635-3904 Fax: 315-635-5525 | |
Dr. Thomas Norbert Helget, O.D. Optometrist Medicare: Not Enrolled in Medicare Practice Location: 22 Endora Dr, Baldwinsville, NY 13027 Phone: 315-635-9679 | |
Malara Eyecare & Eyewear Gallery Optometrist Medicare: Medicare Enrolled Practice Location: 8395 Oswego Rd, Suite 7c, Baldwinsville, NY 13027 Phone: 315-622-3500 Fax: 315-622-3522 | |
Dr. Matthew R Durkin, O.D. Optometrist Medicare: Accepting Medicare Assignments Practice Location: 8395 Oswego Rd, Malara Eyecare And Eyewear Gallery, Baldwinsville, NY 13027 Phone: 315-622-3500 Fax: 315-622-3522 | |
Dr. Mark H Meyers, O.D. Optometrist Medicare: Not Enrolled in Medicare Practice Location: 6291 Mourning Dove, Baldwinsville, NY 13027 Phone: 315-303-4811 |